Rat Tracheal Cartilage Regeneration Using Mesenchymal Stem Cells Derived From Human iPS Cells

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Biomaterials Science

Background:

• Tracheal cartilage damage necessitates surgical repair, with current artificial tracheas lacking biodegradability and pediatric suitability.
• Mesenchymal stem cells (MSCs) are explored for cartilage regeneration, but face challenges in harvesting and supply.
• Human-induced pluripotent stem cell-derived mesenchymal stem cells (iMSCs) offer a potential alternative for cartilage regeneration.

Purpose of the Study:

• To evaluate the potential of iMSCs for regenerating tracheal cartilage.
• To assess the survival and differentiation of iMSCs within a damaged trachea.
• To investigate iMSCs as a viable alternative to non-biodegradable meshes for tracheal reconstruction.

Main Methods:

• iMSCs were generated from human-induced pluripotent stem cells (hiPSCs) via neural crest cells.
• iMSCs were transplanted with a collagen sponge-covered polypropylene mesh into immunodeficient rat tracheal defects.
• Cell survival and chondrogenic differentiation markers (SOX9, type II collagen) were assessed post-transplantation.

Main Results:

• Transplanted iMSCs survived in rat tracheal defects at both 4 and 12 weeks post-transplantation.
• Human nuclear antigen (HNA)-positive cells expressed SOX9 and were surrounded by type II collagen, indicating chondrogenic differentiation.
• Evidence of cartilage-like tissue regeneration was observed, supporting iMSC potential.

Conclusions:

• Transplanted iMSCs can survive and differentiate into chondrogenic cells within tracheal defects.
• iMSC transplantation promotes tracheal cartilage regeneration, offering a promising strategy for airway reconstruction.
• This approach could overcome limitations of current artificial trachea materials, especially for pediatric applications.